SH3PXD2B and cancer: As our results suggest, the absence of Tks4 in epithelial cancer cells can lead to EMT-like features, increased motility and spreading; therefore, targeting the protein or stabilizing its expression levels could be beneficial strategies for future anti-cancer therapies.